Skip to content

Insider · CIK 0001768578

Lori Bisson

director

Files at AMIX (Autonomix Medical, Inc.). First filing -, latest -.

In brief

Lori Bisson files SEC Form 4 as director at AMIX (Autonomix Medical, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Lori Bisson has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 3 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 3, 2026AMIX
Autonomix Medical, Inc.
AGrant or award
Common Stock
+13,000--13,11935 d ago
Aug 11, 2025AMIX
Autonomix Medical, Inc.
DDisposition to issuer
Option (Right to buy)derivative
-18,862--47,930Aug 13, 2025
Aug 11, 2025AMIX
Autonomix Medical, Inc.
DDisposition to issuer
Option (Right to buy)derivative
-46,680--1,250Aug 13, 2025

Questions about Lori Bisson

Answered from the filings on this page, as of the latest one.

Is Lori Bisson buying or selling?

Lori Bisson has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Lori Bisson's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lori Bisson has 0.

Where does Lori Bisson file Form 4?

Lori Bisson has filed Form 4 at AMIX (Autonomix Medical, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Lori Bisson: insider trades and track record | InsiderTell